CA125 Response: Can it Replace the Traditional Response Criteria in Ovarian Cancer?

CA125 Response: Can it Replace the Traditional Response Criteria in Ovarian Cancer? A.E. Guppy, G.J.S. Rustin Oncologist 2002; 7: 437-443 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in gynecologic oncology and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Determine in what situations measuring CA125 levels could alter patient management. Be able to discuss with patients the pros and cons of measuring CA125 during follow-up of ovarian cancer. Be better able to define response or progression of ovarian cancer. Be able to incorporate CA125 use into clinical trial design. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Oct. 25, 2002 Most Recent Review: June 10, 2005* Most Recent Update: Oct. 25, 2002 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.